Cover Image
Market Research Report

Asia Pacific Clinical Nutrition Market By Route of Administration By Application By Country, Industry Analysis and Forecast, 2020 - 2026

Published by KBV Research Product code 941652
Published Content info 104 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Clinical Nutrition Market By Route of Administration By Application By Country, Industry Analysis and Forecast, 2020 - 2026
Published: May 31, 2020 Content info: 104 Pages
Description

Title:
Asia Pacific Clinical Nutrition Market By Route of Administration (Oral, Enteral and Parenteral) By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026.

The Asia Pacific Clinical Nutrition Market would witness market growth of 8.2% CAGR during the forecast period (2020-2026).

Increased prevalence of chronic disorders, and increased numbers of patients using advanced clinical nutrition products, leading towards the growth of the clinical nutrition industry. Increased government R&D investments in health care are also some of the key factors driving the global market for clinical nutrition. The clinical nutrition industry is however hindered by a lack of knowledge and strict regulations. In addition, increased progress in clinical nutrition is expected to offer profitability to global clinical nutrition market players and the growth of various growth opportunities for clinical nutritional products in emerging countries.

Asia-Pacific is expected to grow at the highest growth over the forecast period. The key factors contributing to the growth of the Asia-Pacific clinical nutrition market include a rise in the prevalence of metabolic disorders, an expansion in the geriatric population in the Asia-Pacific region, as well as extensive healthcare spending. The prevalence of diabetes in China is also growing rapidly, which is a major factor in obesity. The actual number of patients diagnosed with metabolic disorders has increased over the last decade, increasing the number of patients diagnosed in the Asia Pacific region.

Most metabolic syndromes lead to situations where the body cannot synthesize non-essential molecules, such as vitamins, amino acids, and several molecules involved in metabolic pathways. Most of these conditions can only be managed with the addition of one or two nutrients. All of these factors are helping the growth of the market. There are, however, few factors that may restrict the market growth.

Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.

Scope of the Study

Market Segmentation:

By Route of Administration

  • Oral
  • Enteral and
  • Parenteral

By Application

  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Metabolic Disorders and
  • Other Applications

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Nestle S.A.
  • Lonza Group AG
  • BASF SE
  • Ajinomoto Co., Inc.
  • Perrigo Company PLC
  • Hero Nutritionals, Inc.

Unique Offerings from KBV Research:

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Clinical Nutrition Market, by Route of Administration
    • 1.4.2 Asia Pacific Clinical Nutrition Market, by Application
    • 1.4.3 Asia Pacific Clinical Nutrition Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Mergers & Acquisitions
    • 3.2.4 Geographical Expansions
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Jan - 2019, Dec) Leading Players
    • 3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2016, Mar - 2019, Oct) Leading Players

Chapter 4. Asia Pacific Clinical Nutrition Market by Route Of Administration

  • 4.1 Asia Pacific Oral Market by Country
  • 4.2 Asia Pacific Enteral Market by Country
  • 4.3 Asia Pacific Parenteral Market by Country

Chapter 5. Asia Pacific Clinical Nutrition Market by Application

  • 5.1 Asia Pacific Cancer Market by Country
  • 5.2 Asia Pacific Neurological Diseases Market by Country
  • 5.3 Asia Pacific Gastrointestinal Disorders Market by Country
  • 5.4 Asia Pacific Metabolic Disorders Market by Country
  • 5.5 Asia Pacific Other Applications Market by Country

Chapter 6. Asia Pacific Clinical Nutrition Market by End User

  • 6.1 Asia Pacific Adults Clinical Nutrition Market by Country
  • 6.2 Asia Pacific Pediatric Market by Country
  • 6.3 Asia Pacific Geriatric Market by Country

Chapter 7. Asia Pacific Clinical Nutrition Market by Country

  • 7.1 China Clinical Nutrition Market
    • 7.1.1 China Clinical Nutrition Market by Route Of Administration
    • 7.1.2 China Clinical Nutrition Market by Application
    • 7.1.3 China Clinical Nutrition Market by End User
  • 7.2 Japan Clinical Nutrition Market
    • 7.2.1 Japan Clinical Nutrition Market by Route Of Administration
    • 7.2.2 Japan Clinical Nutrition Market by Application
    • 7.2.3 Japan Clinical Nutrition Market by End User
  • 7.3 India Clinical Nutrition Market
    • 7.3.1 India Clinical Nutrition Market by Route Of Administration
    • 7.3.2 India Clinical Nutrition Market by Application
    • 7.3.3 India Clinical Nutrition Market by End User
  • 7.4 South Korea Clinical Nutrition Market
    • 7.4.1 South Korea Clinical Nutrition Market by Route Of Administration
    • 7.4.2 South Korea Clinical Nutrition Market by Application
    • 7.4.3 South Korea Clinical Nutrition Market by End User
  • 7.5 Singapore Clinical Nutrition Market
    • 7.5.1 Singapore Clinical Nutrition Market by Route Of Administration
    • 7.5.2 Singapore Clinical Nutrition Market by Application
    • 7.5.3 Singapore Clinical Nutrition Market by End User
  • 7.6 Malaysia Clinical Nutrition Market
    • 7.6.1 Malaysia Clinical Nutrition Market by Route Of Administration
    • 7.6.2 Malaysia Clinical Nutrition Market by Application
    • 7.6.3 Malaysia Clinical Nutrition Market by End User
  • 7.7 Rest of Asia Pacific Clinical Nutrition Market
    • 7.7.1 Rest of Asia Pacific Clinical Nutrition Market by Route Of Administration
    • 7.7.2 Rest of Asia Pacific Clinical Nutrition Market by Application
    • 7.7.3 Rest of Asia Pacific Clinical Nutrition Market by End User

Chapter 8. Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Acquisition and Mergers:
      • 8.1.5.2 Product Launches and Product Expansions:
  • 8.2 B. Braun Melsungen AG
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Product Launches and Product Expansions:
      • 8.2.5.2 Partnerships, Collaborations, and Agreements:
  • 8.3 Baxter International, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Product Launches and Product Expansions:
  • 8.4 Pfizer, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Segmental and Regional Analysis
    • 8.4.3 Research & Development Expense
    • 8.4.4 Recent strategies and developments:
      • 8.4.4.1 Acquisition and Mergers:
  • 8.5 Nestle S.A.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research& Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
      • 8.5.5.2 Product Launches and Product Expansions:
      • 8.5.5.3 Geographical Expansions:
  • 8.6 Lonza Group AG
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
      • 8.6.5.2 Product Launches and Product Expansions:
      • 8.6.5.3 Acquisition and Mergers:
  • 8.7 BASF SE
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Partnerships, Collaborations, and Agreements:
  • 8.8 Ajinomoto Co., Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental & Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Partnerships, Collaborations, and Agreements:
      • 8.8.5.2 Acquisition and Mergers:
  • 8.9 Perrigo Company PLC
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
  • 8.1 Hero Nutritionals, Inc.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 ASIA PACIFIC CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 2 ASIA PACIFIC CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- CLINICAL NUTRITION MARKET
  • TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- CLINICAL NUTRITION MARKET
  • TABLE 5 MERGERS & ACQUISITIONS - CLINICAL NUTRITION MARKET
  • TABLE 6 GEOGRAPHICAL EXPANSIONS - CLINICAL NUTRITION MARKET
  • TABLE 7 ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 8 ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 9 ASIA PACIFIC ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 10 ASIA PACIFIC ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 11 ASIA PACIFIC ENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 12 ASIA PACIFIC ENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 13 ASIA PACIFIC PARENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 14 ASIA PACIFIC PARENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 15 ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 16 ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 17 ASIA PACIFIC CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 18 ASIA PACIFIC CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 19 ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 20 ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 21 ASIA PACIFIC GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 22 ASIA PACIFIC GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 23 ASIA PACIFIC METABOLIC DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 24 ASIA PACIFIC METABOLIC DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 25 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 26 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 27 ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 28 ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 29 ASIA PACIFIC ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 30 ASIA PACIFIC ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 31 ASIA PACIFIC PEDIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 32 ASIA PACIFIC PEDIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 33 ASIA PACIFIC GERIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 34 ASIA PACIFIC GERIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 35 ASIA PACIFIC CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 36 ASIA PACIFIC CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 37 CHINA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 38 CHINA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 39 CHINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 40 CHINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 41 CHINA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 42 CHINA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 43 CHINA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 44 CHINA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 45 JAPAN CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 46 JAPAN CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 47 JAPAN CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 48 JAPAN CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 49 JAPAN CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 50 JAPAN CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 51 JAPAN CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 52 JAPAN CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 53 INDIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 54 INDIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 55 INDIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 56 INDIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 57 INDIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 58 INDIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 59 INDIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 60 INDIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 61 SOUTH KOREA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 62 SOUTH KOREA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 63 SOUTH KOREA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 64 SOUTH KOREA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 65 SOUTH KOREA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 66 SOUTH KOREA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 67 SOUTH KOREA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 68 SOUTH KOREA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 69 SINGAPORE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 70 SINGAPORE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 71 SINGAPORE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 72 SINGAPORE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 73 SINGAPORE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 74 SINGAPORE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 75 SINGAPORE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 76 SINGAPORE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 77 MALAYSIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 78 MALAYSIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 79 MALAYSIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 80 MALAYSIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 81 MALAYSIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 82 MALAYSIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 83 MALAYSIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 84 MALAYSIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 85 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 86 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 87 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 88 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 89 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 90 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 91 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 92 REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 93 KEY INFORMATION - ABBOTT LABORATORIES
  • TABLE 94 KEY INFORMATION - B. BRAUN MELSUNGEN AG
  • TABLE 95 KEY INFORMATION - BAXTER INTERNATIONAL, INC.
  • TABLE 96 KEY INFORMATION - PFIZER, INC.
  • TABLE 97 KEY INFORMATION - NESTLE S.A.
  • TABLE 98 KEY INFORMATION - LONZA GROUP AG
  • TABLE 99 KEY INFORMATION - BASF SE
  • TABLE 100 KEY INFORMATION -AJINOMOTO CO., INC.
  • TABLE 101 KEY INFORMATION - PERRIGO COMPANY PLC
  • TABLE 102 KEY INFORMATION - HERO NUTRITIONALS, INC.

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
  • FIG 2 KBV CARDINAL MATRIX
  • FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
  • FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS : 2016, JAN - 2019, DEC) LEADING PLAYERS
  • FIG 5 KEY STRATEGIC MOVE: (PRODUCT LAUNCHES AND PRODUCT EXPANSIONS : 2016, MAR - 2019, OCT) LEADING PLAYERS
  • FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
  • FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: B. BRAUN MELSUNGEN AG
  • FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NESTLE S.A.
  • FIG 9 RECENT STRATEGIES AND DEVELOPMENTS: LONZA GROUP AG
  • FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: AJINOMOTO CO., INC.
Back to Top